Neumora Therapeutics (NMRA) Tax Provisions (2024 - 2026)
Neumora Therapeutics' (NMRA) quarterly Tax Provisions came in at $30000.0 in Q1 2026, down 71.43% year-on-year from $105000.0 in Q1 2025, and up 160.0% quarter-over-quarter from -$50000.0 in Q4 2025.
Neumora Therapeutics (NMRA) Tax Provisions (2024 - 2026) Analysis & Trends
Neumora Therapeutics' Tax Provisions history runs 3 years deep, the most recent figure standing at $30000.0 for Q1 2026.
- On a quarterly basis, Tax Provisions fell 71.43% year-over-year to $30000.0 in Q1 2026; TTM through Mar 2026 was $5000.0, a 98.23% decrease from a year earlier, with the FY2025 full-year figure at $80000.0, down 55.06% from the prior year.
- Tax Provisions improved to $30000.0 in Q1 2026 per NMRA's latest filing, from -$50000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $125000.0 in Q2 2024 and bottomed at -$50000.0 in Q4 2025.
- The 3-year median for Tax Provisions is $41500.0 (2024), against an average of $48000.0.
- Across the five-year window, Tax Provisions slumped 80.0% in 2025 and plunged 71.43% in 2026, its largest moves.
- Year by year, Tax Provisions stood at $53000.0 in 2024, then plunged by 194.34% to -$50000.0 in 2025, then surged by 160.0% to $30000.0 in 2026.
- Per Business Quant, the three latest NMRA Tax Provisions figures stand at $30000.0 (Q1 2026), -$50000.0 (Q4 2025), and $25000.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Neumora Therapeutics | 270.71 Mn | 270.71 Mn | - | 30,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30,000.00 |
| Dec 31, 2025 | -50,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 105,000.00 |
| Sep 30, 2024 | 53,000.00 |
| Jun 30, 2024 | 125,000.00 |